Biochemical Markers of Musculoskeletal Health and Aging to Be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (Esceo) and the Centre Acad & Eacute;Mique de Recherche Et D'exp & Eacute;Rimentation En Sant & Eacute; (Cares Sprl), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging